Contrast-Induced Nephropathy: A Review of Mechanisms and Risks

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2021 Jun 9

PMID 34104587

Citations 18

Authors

Elham Shams

Harvey N Mayrovitz

Affiliations

Soon will be listed here.

Abstract

Radiological procedures utilizing intravenous iodinated contrast agents are being widely utilized for both therapeutic and diagnostic purposes. This has resulted in an increasing incidence of procedure-related, contrast-induced nephropathy (CIN). CIN is commonly defined as a decline in kidney function occurring in a narrow time window after administration of iodinated contrast agents. Although self-limiting in most cases, CIN carries a risk of more permanent renal insufficiency, dialysis, and death. It remains a common and serious complication among at-risk patients after exposure of contrast agents. Therefore, it is important to identify patients who are at risk during early stages to implement preventative strategies to decrease the incidence of CIN. Minimizing the amount of contrast administered and providing adequate hydration are the cornerstones of an effective preventative approach. This review focuses on the basic concepts of CIN and summarizes the current understanding of its pathophysiology. In addition, it provides practical recommendations with respect to CIN prevention and management.

Citing Articles

Evaluating the Role of Allopurinol in Mitigating Contrast-Induced Nephropathy in Percutaneous Coronary Intervention Patients: A Systematic Review and Meta-Analysis.

Badreldin H, Mallya Prabhakar P Cureus. 2025; 16(12):e76374.

PMID: 39866972 PMC: 11760332. DOI: 10.7759/cureus.76374.

Prognosis modelling of adverse events for post-PCI treated AMI patients based on inflammation and nutrition indexes.

Yang L, Du L, Ge Y, Ou M, Huang W, Wang X BMC Cardiovasc Disord. 2025; 25(1):36.

PMID: 39849369 PMC: 11756209. DOI: 10.1186/s12872-025-04480-7.

Reliability and quality of information provided by artificial intelligence chatbots on post-contrast acute kidney injury: an evaluation of diagnostic, preventive, and treatment guidance.

Ozcan S, Erkan M Rev Assoc Med Bras (1992). 2024; 70(11):e20240891.

PMID: 39630765 PMC: 11639515. DOI: 10.1590/1806-9282.20240891.

Risk Score for Predicting AKI from Contrast-Enhanced CT (Pre-CT AKI score): Training and Validation from Retrospective Cohort.

Pattharanitima P, Bumrungsong N, Phoompho B, Tanin R, Anumas S Kidney360. 2024; .

PMID: 39418104 PMC: 11793181. DOI: 10.34067/KID.0000000623.

Reduction in the risk of contrast-induced nephropathy using enhanced external counter-pulsation in patients with chronic kidney disease.

Zeng C, Pan H, Zhao Y, Ling Z, Liu M, Feng Y Ren Fail. 2024; 46(2):2396449.

PMID: 39319694 PMC: 11425683. DOI: 10.1080/0886022X.2024.2396449.

References

Liss P, Nygren A, Erikson U, ULFENDAHL H . Injection of low and iso-osmolar contrast medium decreases oxygen tension in the renal medulla. Kidney Int. 1998; 53(3):698-702. DOI: 10.1046/j.1523-1755.1998.00811.x. View

Thomsen H, Morcos S . Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines. Br J Radiol. 2003; 76(908):513-8. DOI: 10.1259/bjr/26964464. View

Sterling K, Tehrani T, Rudnick M . Clinical significance and preventive strategies for contrast-induced nephropathy. Curr Opin Nephrol Hypertens. 2008; 17(6):616-23. DOI: 10.1097/MNH.0b013e32830f45a3. View

Aspelin P, Aubry P, Fransson S, Strasser R, Willenbrock R, Berg K . Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med. 2003; 348(6):491-9. DOI: 10.1056/NEJMoa021833. View

Heyman S, Rosenberger C, Rosen S, Khamaisi M . Why is diabetes mellitus a risk factor for contrast-induced nephropathy?. Biomed Res Int. 2013; 2013:123589. PMC: 3856131. DOI: 10.1155/2013/123589. View

Hyngstrom J, Chiang Y, Cromwell K, Ross M, Xing Y, Mungovan K . Prospective assessment of lymphedema incidence and lymphedema-associated symptoms following lymph node surgery for melanoma. Melanoma Res. 2013; 23(4):290-7. PMC: 3881422. DOI: 10.1097/CMR.0b013e3283632c83. View

Mamoulakis C, Tsarouhas K, Fragkiadoulaki I, Heretis I, Wilks M, Spandidos D . Contrast-induced nephropathy: Basic concepts, pathophysiological implications and prevention strategies. Pharmacol Ther. 2017; 180:99-112. DOI: 10.1016/j.pharmthera.2017.06.009. View

Bachorzewska-Gajewska H, Poniatowski B, Dobrzycki S . NGAL (neutrophil gelatinase-associated lipocalin) and L-FABP after percutaneous coronary interventions due to unstable angina in patients with normal serum creatinine. Adv Med Sci. 2009; 54(2):221-4. DOI: 10.2478/v10039-009-0036-1. View

Dixit M, Doan T, Kirschner R, Dixit N . Significant Acute Kidney Injury Due to Non-steroidal Anti-inflammatory Drugs: Inpatient Setting. Pharmaceuticals (Basel). 2016; 3(4):1279-1285. PMC: 4034033. DOI: 10.3390/ph3041279. View

10.

Ellis J, Cohan R . Prevention of contrast-induced nephropathy: an overview. Radiol Clin North Am. 2009; 47(5):801-11, v. DOI: 10.1016/j.rcl.2009.06.003. View

11.

Gleeson T, Bulugahapitiya S . Contrast-induced nephropathy. AJR Am J Roentgenol. 2004; 183(6):1673-89. DOI: 10.2214/ajr.183.6.01831673. View

12.

Mueller C, Buerkle G, Buettner H, Petersen J, Perruchoud A, Eriksson U . Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med. 2002; 162(3):329-36. DOI: 10.1001/archinte.162.3.329. View

13.

Bragadottir G, Redfors B, Ricksten S . Assessing glomerular filtration rate (GFR) in critically ill patients with acute kidney injury--true GFR versus urinary creatinine clearance and estimating equations. Crit Care. 2013; 17(3):R108. PMC: 4056314. DOI: 10.1186/cc12777. View

14.

McCullough P, Wolyn R, Rocher L, Levin R, ONeill W . Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med. 1997; 103(5):368-75. DOI: 10.1016/s0002-9343(97)00150-2. View

15.

Simsek A, Tugcu V, Tasci A . New biomarkers for the quick detection of acute kidney injury. ISRN Nephrol. 2014; 2013:394582. PMC: 4045421. DOI: 10.5402/2013/394582. View

16.

Pattharanitima P, Tasanarong A . Pharmacological strategies to prevent contrast-induced acute kidney injury. Biomed Res Int. 2014; 2014:236930. PMC: 3955653. DOI: 10.1155/2014/236930. View

17.

Rudnick M, Goldfarb S, Wexler L, Ludbrook P, Murphy M, Halpern E . Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int. 1995; 47(1):254-61. DOI: 10.1038/ki.1995.32. View

18.

Gupta R, Bang T . Prevention of Contrast-Induced Nephropathy (CIN) in Interventional Radiology Practice. Semin Intervent Radiol. 2012; 27(4):348-59. PMC: 3324211. DOI: 10.1055/s-0030-1267860. View

19.

Katzberg R, Newhouse J . Intravenous contrast medium-induced nephrotoxicity: is the medical risk really as great as we have come to believe?. Radiology. 2010; 256(1):21-8. DOI: 10.1148/radiol.10092000. View

20.

Wagener G, Jan M, Kim M, Mori K, Barasch J, Sladen R . Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology. 2006; 105(3):485-91. DOI: 10.1097/00000542-200609000-00011. View